Dr. Sameer Khatri

Dr. Sameer Khatri
Medical Oncologist, Delhi

MBBS, MD, DNB (Medical Oncology)

  • 1 Hospital
  • 17 Years Experience
  • Medical Oncology with over 15 years of experience in the field of oncology

Specialities

  • Medical Oncology

Expertise

Education

MBBS, 1994, Maulana Azad Medical College and associated Lok Nayak Jayprakash Hospital, Delhi, India

MD, 1999, Maulana Azad Medical College and associated Lok Nayak Jayprakash Hospital, Delhi, India

DNB (Medical Oncology), 2006, Rajiv Gandhi Cancer Institute, Delhi, India

Practice Information

HCG SMH - Curie Cancer Centre, Delhi

HCG SMH - Curie Cancer Centre, Delhi

#2, Institutional Area, Vikas Marg Extn, Karkardooma, Delhi, Delhi - 110092

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Sameer Khatri and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Phase IV Clinical Trial - A retrospective evaluation of efficacy and safety of chemotherapeutic formulations of Fresenius kabi Oncology (Gemcitabine, Docetaxel, Irinotecan, Oxaliplation and Paclitaxel versus historical data in CRC, SCCHN, NSCLC, pancreatic carcinoma, gastric adenocarcinoma). [Principal Investigator]
  • Phase II Trial of Bavituximab plus Docetexel in patients with previously treated locally advanced or metastatic non- squamous non-small cell lung cancer. [Principal Investigator]
  • A randomised, multi-centre, double-blind, parallel group study to compare the pharmacokinetics, pharmacodynamics, safety and efficacy of two anti-CD20 monoclonal antibodies in combination with CHOP in patients with CD20-positive diffuse large B-cell lymphoma. [Principal Investigator].
  • First in paper presentation category. "Pyopneumopericardium following Odontogenic Ludwig's Angina". 57th Joint Annual Conference API. Chennai. - Jan 2002
  • First in paper presentation category. "Clinical Benefit Response with Gemcitabine and Platinum in Advanced / Metastatic Pancreas – RGCI Experience". RGCON 2004, 3rd International Conference of RGCI. New Delhi. - Apr 2004
  • First in poster presentation category. "Clinical Profile of Hepatocellular Carcinoma". RGCON 2004, 3rd International Conference of RGCI. New Delhi. - Apr 2004
  • Tuberculous liver abscess mimicking amoebic liver. Journal of Association of Physicians of India. 2002; Vol. 50.
  • Neurocognitive characterization of age associated cognitive decline. Journal of Association of Physicians of India. 2002; Vol. 50.
  • Neuroendocrine carcinoma of gall bladder 2 cases. Published in RGCON 2004, 3rd International Conference of Rajiv Gandhi Cancer Institute and Research Centre, Delhi.
  • Clinical profile of hepatocellular carcinoma. Published in RGCON 2004, 3rd International Conference of Rajiv Gandhi Cancer Institute and Research Centre, Delhi.
  • Ovarian metastasis from carcinoma gall bladder. Published in RGCON 2004, 3rd International Conference of Rajiv Gandhi Cancer Institute and Research Centre, Delhi.
  • Adamantiades-Behcet's disease and CML: a case report and review of literature. Haema. 2006;9(4): 579-581.
  • Pronostic significance of blast in the cerebrospinal fluid without pleiocytosis or a traumatic lumber puncture in children with acute lymphoblastic leukaemia: Experience of the Dutch childhood oncology group. Selected Summary. Indian J Med Paediatric Oncology. 2006; Volume :27 I Issue : 4 I Page: 21-24.
  • Migration of entire peripherally-inserted central catheter to pulmonary arteries: an unusal complication. IJMPO. 2007; 28(1): 33-36.
  • Paraneoplastic hypercalcaemia in association with metabolic complication in advanced carcinoma of oral cavity. IJMPO. 2007; 28 (2); 44-46.
  • Altretamine revisited in advanced pretreated epithelial ovarian carcinoma patients; experience from a centre from North India. Annals of Oncology 19. Jul 2008; (Supplement 5); v150-v151. (doi;10.1093/mdn335).
  • Metastatic signet-ring cell gastric carcinoma masquerading as breast primary. Karger. 2009; 3: 21-25.